NAD(P)H oxidase in paraventricular nucleus contributes to the effect of angiotensin II on cardiac sympathetic afferent reflex

Brain Research

Volumn 1082, Issue 1, 2006, Pages 132-141

  Zhang, Ying ^a   Yu, Yang ^a   Zhang, Feng ^a   Zhong, Ming Kui ^a   Shi, Zhen ^a   Gao, Xing Ya ^a   Wang, Wei ^b   Zhu, Guo Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Cardiovascular reflex; NAD(P)H oxidase; Paraventricular nucleus; Reactive oxygen species; Sympathetic activity

Indexed keywords

ALLOPURINOL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; APOCYNIN; ARSENOSOBENZENE; BRADYKININ; LOSARTAN; LUCIGENIN; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERIAL PRESSURE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; EPICARDIUM; EVALUATION; HEART DENERVATION; HEART FUNCTION; HORMONE ACTION; KIDNEY NERVE; MALE; MEASUREMENT; MICROINJECTION; MODULATION; NERVE BLOCK; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECORDING; SENSORY NERVE; SINUS NODE; SYMPATHETIC NERVE; SYMPATHETIC REFLEX; THALAMUS MIDLINE NUCLEUS; VAGOTOMY;

AFFERENT PATHWAYS; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; HEART; MALE; MICROINJECTIONS; NADPH OXIDASE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTOR AGENTS;

ANIMALIA;

EID: 33645862260     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.113     Document Type: Article

References (52)

1. Bains J.S., Potyok A., and Ferguson A.V. Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res. 599 (1992) 223-229
2. Ben-Shaul V., Lomnitski L., Nyska A., Zurovsky Y., Bergman M., and Grossman S. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol. Lett. 123 (2001) 1-10
3. Bendall J.K., Cave A.C., Heymes C., Gall N., and Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105 (2002) 293-296
4. Biagi P., and Abate L. Heart failure, oxidative stress and allopurinol. Monaldi Arch. Chest Dis. 64 (2005) 33-37
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24 (2003) 471-478
7. Chalmers R.A., Kromer H., Scott J.T., and Watts R.W. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man. Clin. Sci. 35 (1968) 353-362
8. Cifuentes M.E., Rey F.E., Carretero O.A., and Pagano P.J. Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H2234-H2240
9. de Groot A.A., van Zwieten P.A., and Peters S.L. Involvement of reactive oxygen species in angiotensin II-induced vasoconstriction. J. Cardiovasc. Pharmacol. 43 (2004) 154-159
10. Dodd O., and Pearse D.B. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H303-H312
11. Doussiere J., Poinas A., Blais C., and Vignais P.V. Phenylarsine oxide as an inhibitor of the activation of the neutrophil NADPH oxidase-identification of the beta subunit of the flavocytochrome b component of the NADPH oxidase as a target site for phenylarsine oxide by photoaffinity labeling and photoinactivation. Eur. J. Biochem. 251 (1998) 649-658
12. Gao L., Wang W., Li Y.L., Schultz H.D., Liu D., Cornish K.G., and Zucker I.H. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ. Res. 95 (2004) 937-944
13. Gao L., Schultz H.D., Patel K.P., Zucker I.H., and Wang W. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 45 (2005) 1173-1181
14. Griendling K.K., and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 91 (2000) 21-27
15. Griendling K.K., Minieri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
16. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
17. Han Y., Zhang Y., Wang H.J., Gao X.Y., Wang W., and Zhu G.Q. Reactive oxygen species in paraventricular nucleus modulates cardiac sympathetic afferent reflex in rats. Brain Res. 1058 (2005) 82-90
18. Kazama K., Anrather J., Zhou P., Girouard H., Frys K., Milner T.A., and Iadecola C. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ. Res. 95 (2004) 1019-1026
19. Knapp L.T., and Klann E. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory?. J. Neurosci. Res. 70 (2002) 1-7
20. Kuzmin A.I., Tskitishvili O.V., Serebryakova L.I., Kapelko V.I., Majorova I.V., and Medvedev O.S. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis. J. Cardiovasc. Pharmacol. 25 (1995) 564-571
21. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 285 (2003) R277-R297
22. Li J.M., and Shah A.M. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277 (2002) 19952-19960
23. Li J.M., and Shah A.M. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S221-S226
24. Li J.M., and Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J. Biol. Chem. 278 (2003) 12094-12100
25. Lodha S., Dani D., Mehta R., Bhaskaran M., Reddy K., Ding G., and Singhal P.C. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol. Med. 8 (2002) 830-840
26. Ma R., Zhu G.Q., and Wang W. Interaction of central Ang II and NO on the cardiac sympathetic afferent reflex in dogs. Auton. Neurosci. 118 (2005) 51-60
27. Malliani A., and Montano N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39 (2002) 63-68
28. Massey V., Komai H., Palmer G., and Elion G.B. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines. J. Biol. Chem. 245 (1970) 2837-2844
29. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., Li H., Bodenschatz M., August M., Kleschyov A.L., Tsilimingas N., Walter U., Forstermann U., Meinertz T., Griendling K., and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90 (2002) E58-E65
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. (2005), Elsevier Academic Press, San Diego
31. Riedel A.A., Nelson M., Joseph-Ridge N., Wallace K., MacDonald P., and Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J. Rheumatol. 31 (2004) 1575-1581
32. Rueckschloss U., Quinn M.T., Holtz J., and Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler., Thromb., Vasc. Biol. 22 (2002) 1845-1851
33. Serrano F., Kolluri N.S., Wientjes F.B., Card J.P., and Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res. 988 (2003) 193-198
34. Souza H.P., Cardounel A.J., and Zweier J.L. Mechanisms of free radical production in the vascular wall. Coron. Artery Dis. 14 (2003) 101-107
35. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11 (1994) 95-102
36. Sun C., Sellers K.W., Sumners C., and Raizada M.K. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ. Res. 96 (2005) 659-666
37. Suzukawa K., Miura K., Mitsushita J., Resau J., Hirose K., Crystal R., and Kamata T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J. Biol. Chem. 275 (2000) 13175-13178
38. Tejada-Simon M.V., Serrano F., Villasana L.E., Kanterewicz B.I., Wu G.Y., Quinn M.T., and Klann E. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol. Cell. Neurosci. 29 (2005) 97-106
39. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz. J. Med. Biol. Res. 37 (2004) 1263-1273
40. Wang W., and Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Failure Rev. 5 (2000) 57-71
41. Wang W., Zhu G.Q., Schultz H.D., and Zucker I.H. nNOS inhibition potentiates the central effects of angiotensin II on the cardiac sympathetic afferent reflex. Circulation 102 (2000) II350
42. Wang W., Zhu G.Q., and Zucker I.H. Modulation of the cardiac sympathetic afferent reflex by nitric oxide in the paraventricular nucleus of dogs with chronic heart failure. Circulation 104 (2001) II739
43. Wang G., Anrather J., Huang J., Speth R.C., Pickel V.M., and Iadecola C. NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J. Neurosci. 24 (2004) 5516-5524
44. Wang H.J., Zhang F., Zhang Y., Gao X.Y., Wang W., and Zhu G.Q. AT(1) receptor in paraventricular nucleus mediates the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Auton. Neurosci. 121 (2005) 56-63
45. Wright J.W., and Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci. Biobehav. Rev. 18 (1994) 21-53
46. Zekry D., Epperson T.K., and Krause K.H. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?. IUBMB Life 55 (2003) 307-313
47. Zhu G.Q., Patel K.P., Zucker I.H., and Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H2039-H2045
48. Zhu G.Q., Zucker I.H., and Wang W. Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Basic Res. Cardiol. 97 (2002) 320-326
49. Zhu G.Q., Gao L., Li Y., Patel K.P., Zucker I.H., and Wang W. AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am. J. Physiol.: Heart Circ. Physiol. 287 (2004) H1828-H1835
50. Zhu G.Q., Gao L., Patel K.P., Zucker I.H., and Wang W. ANG II in the paraventricular nucleus potentiates the cardiac sympathetic afferent reflex in rats with heart failure. J. Appl. Physiol. 97 (2004) 1746-1754
51. Zimmerman M.C., and Davisson R.L. Redox signaling in central neural regulation of cardiovascular function. Prog. Biophys. Mol. Biol. 84 (2004) 125-149
52. Zimmerman M.C., Dunlay R.P., Lazartigues E., Zhang Y., Sharma R.V., Engelhardt J.F., and Davisson R.L. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95 (2004) 532-539